BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/1/2014 11:02:00 AM | Browse: 1060 | Download: 623
Publication Name World Journal of Gastroenterology
Manuscript ID 5898
Country Denmark
Received
2013-09-28 19:05
Peer-Review Started
2013-09-29 16:18
To Make the First Decision
2013-12-16 17:07
Return for Revision
2013-12-17 15:23
Revised
2014-01-13 23:04
Second Decision
2014-02-20 15:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-02-20 15:56
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-03-07 17:18
Publish the Manuscript Online
2014-03-27 12:04
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Biomarkers in inflammatory bowel diseases: Current status and proteomics identification strategies
Manuscript Source Invited Manuscript
All Author List Tue Bennike, Svend Birkelund, Allan Stensballe and Vibeke Andersen
Funding Agency and Grant Number
Corresponding Author Vibeke Andersen, MD, PhD, Organ Center, Hospital of Southern Jutland, Kresten Philipsens Vej 15, 6200 Aabenraa, Denmark. vibeke.andersen1@rsyd.dk
Key Words Inflammatory bowel disease; Biomarker; Proteomics; Citrullination; Ulcerative colitis; Crohn’s disease; Posttranslational modification
Core Tip Establishing the correct diagnose of Crohn’s disease and ulcerative colitis (UC) patients remains troublesome, and correct and early medication is critical. No reliable biomarkes have been implemented in clinical usage, to distinguish between Crohn’s disease patients and UC patients. Considering the protein complexity encountered in intestinal biopsy samples and the recent development within the field of quantitative proteomics, submitting the intestinal mucosa to a more thorough analysis has the potential to reveal new biomarkers.
Publish Date 2014-03-27 12:04
Citation Bennike T, Birkelund S, Stensballe A, Andersen V. Biomarkers in inflammatory bowel diseases: Current status and proteomics identification strategies. World J Gastroenterol 2014; 20(12): 3231-3244
URL http://www.wjgnet.com/1007-9327/full/v20/i12/3231.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i12.3231
Full Article (PDF) WJG-20-3231.pdf
Full Article (Word) WJG-20-3231.doc
Manuscript File 5898-Review.doc
Answering Reviewers 5898-Answering reviewers.pdf
Copyright License Agreement 5898-Copyright assignment.pdf
Peer-review Report 5898-Peer reviews.pdf
Scientific Editor Work List 5898-Scientific editor work list.doc